Bernard is Managing Partner of CapGenic Advisors, CFO of Atrin Pharmaceuticals and Chief Business Officer of NovoBioPharma. He is an active angel investor with the Philadelphia Chapter of Keiretsu Forum as well as with Mid Atlantic Bio Angels and Minority Angel Investor Network. Bernie's entrepreneurial career spans a number of startups, three of which grew to over $50 million in revenue before liquidity events.
He is a founder of one of the nation's leading entrepreneurial programs (MADV) at the Fox School of Business; director of Operative Experience, Axxia Pharmaceuticals, and RSportz; and has held a number of other board positions - both commercial and not-for-profit - throughout his career. With 38 years of experience in executive-level strategy, finance, and management, Bernie has senior merger, acquisition, capital formation, and licensing leadership experience with companies ranging from startups to Fortune 50s. He has substantial experience investing and guiding investments in entrepreneurial companies and has led capital formation totaling more than $538 million and strategic and licensing transactions of over $7 billion in the past 22 years.